Chisos Capital, established in 2020 and headquartered in Santa Monica, California, is a venture capital firm that specializes in providing financial support to high-potential athletes, entrepreneurs, and creators. The company writes checks ranging from $25,000 to $100,000 using Convertible Income Share Agreement terms, which allows it to invest in individuals with promising futures across various fields.
Axio BioPharma is a Contract Development and Manufacturing Organization (CDMO) based in Madison, Wisconsin, specializing in the development and production of mammalian-expressed recombinant proteins, particularly monoclonal antibodies. The company employs an artificial intelligence-based approach to streamline the transition from laboratory research to clinical manufacturing, significantly reducing timelines and enhancing efficiency. Their services encompass construct optimization, expression process development, purification process development, and both research-grade and GMP (Good Manufacturing Practice) manufacturing. Through these capabilities, Axio BioPharma aims to accelerate the delivery of critical therapies to patients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.